




























Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
He, B-T., Lu, G., Xiao, S-C., Chen, R., Steier, J., Moxham, J., ... Luo, Y-M. (2016). Coexistence of OSA may
compensate for sleep related reduction in neural respiratory drive in patients with COPD. Thorax, 1-7.
10.1136/thoraxjnl- 2016-208467
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
ORIGINAL ARTICLE
Coexistence of OSA may compensate for sleep
related reduction in neural respiratory drive in
patients with COPD
Bai-Ting He,1 Gan Lu,2 Si-Chang Xiao,1 Rui Chen,3 Joerg Steier,4 John Moxham,4
Michael I Polkey,5 Yuan-Ming Luo1
▸ Additional material is
published online only. To view
please visit the journal online
(http://dx.doi.org/10.1136/
thoraxjnl-2016-208467).








Hospital of Soochow University,
Suzhou, China




Research Unit, The Royal
Brompton and Hareﬁeld NHS




Professor YM Luo, State Key
Laboratory of Respiratory




Dr R Chen, Department of
Respiratory Medicine, Second
Afﬁliated Hospital of Soochow
University, Suzhou, China;
chenruigood@126.com
BH, GL and SX contributed
equally to this work.
Received 9 February 2016
Revised 9 September 2016
Accepted 5 October 2016
To cite: He B-T, Lu G,
Xiao S-C, et al. Thorax
Published Online First:




Background The mechanisms underlying sleep-related
hypoventilation in patients with coexisting COPD and
obstructive sleep apnoea (OSA), an overlap syndrome,
are incompletely understood. We compared neural
respiratory drive expressed as diaphragm electromyogram
(EMGdi) and ventilation during stage 2 sleep in patients
with COPD alone and patients with overlap syndrome.
Methods EMGdi and airﬂow were recorded during full
polysomnography in 14 healthy subjects, 14 patients
with OSA and 39 consecutive patients with COPD. The
ratio of tidal volume to EMGdi was measured to
indirectly assess upper airway resistance.
Results Thirty-ﬁve patients with COPD, 12 healthy
subjects and 14 patients with OSA completed the study.
Of 35 patients with COPD, 19 had COPD alone (FEV1
38.5%±16.3%) whereas 16 had an overlap syndrome
(FEV1 47.5±16.2%, AHI 20.5±14.1 events/hour).
Ventilation (VE) was lower during stage 2 sleep than
wakefulness in both patients with COPD alone (8.6±2.0
to 6.5±1.5 L/min, p<0.001) and those with overlap
syndrome (8.3±2.0 to 6.1±1.8 L/min). Neural respiratory
drive from wakefulness to sleep decreased signiﬁcantly
for patients with COPD alone (29.5±13.3% to 23.0
±8.9% of maximal, p<0.01) but it changed little in
those with overlap syndrome. The ratio of tidal volume
to EMGdi was unchanged from wakefulness to sleep in
patients with COPD alone and healthy subjects but was
signiﬁcantly reduced in patients with OSA or overlap
syndrome (p<0.05).
Conclusions Stage 2 sleep-related hypoventilation in
COPD alone is due to reduction of neural respiratory
drive, but in overlap syndrome it is due to increased
upper airway resistance.
INTRODUCTION
COPD is a common condition and patients with
COPD are subject to hypoxaemia or even respira-
tory failure during sleep because of hypoventila-
tion.1 2 In prior reports we showed that this
hypoventilation, in the absence of upper airway
obstruction was due to a reduction in neural
respiratory drive to the respiratory muscles as mea-
sured by the diaphragm electromyogram
(EMGdi).
2 3 Obstructive sleep apnoea (OSA) is
characterised by repeated partial or complete col-
lapse of the upper airway leading to increased
upper airway resistance and arousal from sleep
which are associated with increased neural respira-
tory drive.4 5
It has been previously reported that nocturnal
oxygen desaturation is more severe in patients with
COPD and OSA, a phenotype termed the ‘overlap
syndrome’, than those with COPD alone.6
However, this view is mainly based on the results
derived from patients with mild or moderate
COPD and predominant OSA who are often
obese7 8 and may not be the case for patients with
more severe COPD.9 In contrast to the hypoventi-
lation in patients with COPD, OSA is characterised
by increased upper airway resistance and is asso-
ciated with an increase in neural respiratory
drive.2 4 5 10 If patients with severe COPD develop
OSA, the sleep-related reduction in neural respira-
tory drive associated with COPD could be offset by
an increase in neural respiratory drive due to
increased upper airway resistance. Consequently,
ventilation in patients with severe COPD may not
further decrease when COPD and mild or modest
OSA occur together.
The EMGdi recorded from a multipair oesopha-
geal electrode can be used to assess neural respira-
tory drive,2 4 5 10 11 and upper airway resistance
Key messages
What is the key question?
▸ The mechanisms underlying sleep-related
hypoventilation in patients with coexistent
COPD and obstructive sleep apnoea (OSA), an
overlap syndrome, are unknown.
What is the bottom line?
▸ This study shows that sleep-related
hypoventilation in patients with overlap
syndrome is due to an increase in upper airway
resistance associated with OSA rather than
reduction of neural respiratory drive associated
with COPD.
Why read on?
▸ Sleep-related hypoventilation in patients with
COPD alone mainly occurs because of a
decrease in neural respiratory drive whereas it
is mainly a result of an increase in upper
airway resistance in patients with overlap
syndrome.
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can be inferred by the ratio of the tidal volume (VT) to EMGdi
(VT/EMGdi) assuming that lung mechanics and lower airway
resistance remain constant in wakefulness and sleep.2 Here we
aimed to investigate the underlying mechanisms of hypoventila-
tion during sleep in patients with COPD alone and patients
with overlap syndrome by comparing neural respiratory drive
and ventilation. The data from 10 of the patients with COPD
alone and 10 healthy subjects has previously been reported;




Thirty-nine consecutive patients with COPD from the outpatient
clinic of Guangzhou Institute of Respiratory Disease were
studied, including 10 patients whose data were reported previ-
ously.2 Exclusion criteria were a known diagnosis of OSA before
the study, clinically signiﬁcant coexisting diseases including car-
diovascular and neuromuscular disease, an acute exacerbation of
COPD in the preceding month, FEV1<20% predicted, and use
of long-term oxygen therapy. Usual medications including
inhaled bronchodilators were allowed for all the patients.
Fourteen healthy subjects and 14 patients with OSA were also
studied; as noted 10 of the healthy subjects had appeared in our
prior report.2 The study was approved by the Ethics Committee
of the First Afﬁliated Hospital of Guangzhou Medical University
and all subjects gave written informed consent.
Lung function tests
Spirometry (Cosmed Micro Quark, Cosmed, Italy) was per-
formed on the same night as polysomnography. Measurements
were repeated until maximal reproducible values of FEV1 were
achieved with variation of less than 150 ml between tests. The
modiﬁed Medical Research Council dyspnoea scale (mMRC)
was also recorded before polysomnography.
Oesophageal electrode and its positioning
A soft ﬁne catheter with an external diameter of 1.6 mm was
used to record the EMGdi. The catheter had 10 metal coils
which provided ﬁve pairs of recording electrodes was used to
record the EMGdi. The oesophageal electrode was passed
through the nose into the stomach and was carefully positioned
based on the EMGdi amplitude recorded simultaneously from
the ﬁve pairs of electrodes, as reported previously.4 12 Brieﬂy
the position of the electrode catheter was judged to be optimal
when electrode 5 was located at the level of the diaphragm con-
ﬁrmed by the amplitude of EMGdi activity being greatest in
pairs 1 and 5, and smallest in pair 3 during inspiration. When
the electrode catheter was in the optimal position, it was
securely taped at the nose. The EMGdi signals were ampliﬁed
and band-pass ﬁltered between 20 Hz and 1 kHz (RA-8, Yinghui
Medical Technology Co., Guangzhou, China).
Measurement of maximal EMGdi
Maximal EMGdi was recorded during two manoeuvres:
maximal inspiration to total lung capacity (TLC) and maximal
inspiration against a closed airway at functional residual capacity
for 3 s. Each manoeuvre was repeatedly performed until subjects
were able to master the techniques. More than three maximal
efforts, with an interval of 30 s or more between them, were
recorded for analysis and the largest single value was considered
maximal.
Polysomnography
Full overnight polysomnograms including the EEG (C3-A2,
C4-A1), left and right electro-oculograms (EOG), submental
electromyogram (EMGchin), airﬂow, snoring, body position,
oxygen saturation and end-tidal CO2 were recorded. Airﬂow
was recorded with a pneumotachgraph connected to a full face-
mask, and integrated to produce volume. All signals were
recorded simultaneously using a Powerlab recording system
(ADInstruments, Castle Hill, Australia). The sampling rate was
2 kHz for EMGdi and 200 Hz for other signals. EMGdi was
recorded before and during sleep.
Analysis of data
Conventional polysomnography was manually analysed based
on standard criteria.13 An obstructive apnoea event was deﬁned
as absence of airﬂow for longer than 10 s, while there was
phasic inspiratory EMGdi.
10 13 A hypopnoea event was deﬁned
as reduction of airﬂow of more than 30% for longer than 10 s
associated with ≥3% desaturation or the event being associated
with arousal.13 Overlap syndrome was deﬁned as apnoea hypop-
noea index (AHI) ≥5 events/hour in the presence of COPD.
Clinically signiﬁcant sleep-related desaturation was deﬁned as
SaO2<90% which lasted longer than 5 min. The root mean
square of the EMGdi was calculated by computer with a time
constant of 100 ms. The root mean square reported was that
from the electrode pair with the largest EMGdi amplitude for
each breathing cycle. To avoid the inﬂuence of the electrocardio-
gram on the EMGdi, root mean square was measured from seg-
ments between QRS complexes. A ratio of VT to root mean
square of EMGdi (VT/EMGdi) of each breath was used to assess
upper airway resistance.2 Data were selected during stable
breathing without respiratory events unless stated otherwise.
Ten minutes of data before sleep and at least 14 min during
stage 2 in the supine position were selected for analysis.
To further conﬁrm that the VT/EMGdi could be used to assess
change in upper airway resistance from wakefulness to sleep, we
measured VT/EMGdi during wakefulness, during snoring and
hypopnoea events in patients with overlap syndrome. At least
50 breathing cycles were measured for each condition.
Data were presented as mean±SD. The Wilcoxon rank sum
test and Kruskal–Wallis test followed by Dunn’s test were used
to test for differences between groups as appropriate. Statistical
signiﬁcance was determined by p<0.05.
RESULTS
Four patients with COPD and two healthy subjects could not
tolerate the oesophageal catheter or full face mask connected to
the pneumotachgraph, therefore ﬁnal data were derived from 35
patients with COPD, 12 healthy subjects and 14 patients with
OSA (see table 1 and online supplementary table E-1). Using the
above criteria 16 of the patients with COPD were found to have
overlap syndrome (FEV1 47.5±16.2%; AHI 20.5±14.1 events/
hour) and 19 patients had COPD alone (FEV1 38.5±16.3%;
AHI 1.9±1.6). The body mass index (BMI) in patients
with COPD alone (19.9±2.7 kg/m2) was signiﬁcantly lower than
that in patients with overlap syndrome (23.5±3.8 kg/m2)
(p<0.05). The FEV1 in patients with COPD alone was not sig-
niﬁcantly different from that in patients with overlap syndrome
(38.5%±16.3% vs 47.5%±16.2%, p>0.05). The respiratory
events in patients with overlap syndrome were predominantly
hypopnoea rather than apnoea, except for subject 1 (see table 1
and online supplementary table E-2). Overall, the ratio of
hypopnoea to apnoea events in patients with overlap syndrome
2 He B-T, et al. Thorax 2016;0:1–7. doi:10.1136/thoraxjnl-2016-208467
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was 4.4:1. COPD alone and overlap syndrome groups were
similar to each other but, as expected, had signiﬁcantly greater
dyspnoea compared with healthy subjects and patients with OSA
(p<0.001). The maximal EMGdi was similar between groups
and was 176.9±72.1, 192.3±56.6, 156.1±50.3, 166.2
±40.8 μV for COPD alone, patients with overlap syndrome,
healthy subjects and patients with OSA (p>0.05), respectively.
The mean SaO2% over the entire sleep period was 96.8±1.4,
97.1±1.3, 98.0±1.0 and 96.9±0.7 during wakefulness and 96.0
±1.6, 95.8±1.4, 97.6±0.9 and 96.1±1.4 during sleep for
patients with COPD alone, patients with overlap syndrome,
healthy subjects and patients with OSA, respectively. COPD
alone and overlap syndrome groups were similar to each other
but had a lower mean minimal SaO2% during overnight sleep
compared with healthy subjects (see table 1 and online
supplementary table E-2). Mean minimal SaO2% in patients with
OSAwas lower than those in the other three groups. Three of 19
(16%) patients with COPD alone developed SaO2<90% for
longer than 5 min, whereas no subjects in both the patients with
overlap syndrome and the healthy subjects developed signiﬁcant
oxygen desaturation (see online supplementary table E-2).
Ventilation in patients with COPD, patients with overlap
syndromes, healthy subjects and those with OSA during
wakefulness and sleep
VE was similar between groups and was 8.6±2.0, 8.3±2.0, 8.3
±1.6 and 8.0±2.7 L/min for patients with COPD alone,
patients with overlap syndromes, healthy subjects and patients
with OSA during wakefulness (p>0.05). VE decreased signiﬁ-
cantly from wakefulness to non-rapid eye movement (NREM)
sleep for patients with COPD alone (8.6±2.0 to 6.5±1.5 L/
min, p<0.001), patients with overlap syndrome (8.3±2.0 to 6.1
±1.8 L/min, p<0.001) and patients with OSA (8.0±2.7 to 6.3
±1.9 L/min, p<0.01), although the change in VE failed to
attain statistical signiﬁcance between wakefulness and NREM
sleep in healthy subjects (8.3±1.6 to 7.5±1.3 L/min, p=0.07).
The decrease in VE from wakefulness to sleep was similar
between patients with COPD and patients with overlap
syndrome (24% vs 27%, p>0.05), but it was greater in both
groups than that observed in healthy subjects (10%), p<0.05.
Change in VE was almost proportional to change in VT in
patients with COPD, patients with overlap syndrome and
patients with OSA (table 2, ﬁgures 1 and 2).
Neural respiratory drive decreased signiﬁcantly in patients
with COPD alone (29.5±13.3% vs 23.0±8.9% of maximal
EMGdi, p<0.01), but increased signiﬁcantly in patients with
OSA (14.2±7.9% vs 23.4±10.8% of maximal EMGdi) from
wakefulness to NREM sleep. However, neural respiratory drive
changed little from wakefulness to stage 2 sleep in patients with
overlap syndrome (29.3±15.8% vs 27.3±14.7% of maximal
EMGdi, p>0.05) and in healthy subjects (12.6±3.7% vs 12.2
±3.3% of maximal EMGdi, p>0.05). Respiratory rate also
changed little between wakefulness and NREM sleep in all four
groups (p>0.05). VT/EMGdi was similar between wakefulness
and NREM sleep in both healthy subjects (0.69±0.18 vs 0.69
±0.20) and patients with COPD alone (0.39±0.23 vs 0.37
±0.21) but it decreased signiﬁcantly from wakefulness to sleep
in patients with overlap syndrome (0.35±0.21 vs 0.28±0.19,
p<0.05) and patients with OSA (0.56±0.24 vs 0.28±0.13,
p<0.01) (see table 2 and online supplementary tables E-3 and
E-4, and supplementary ﬁgure E-1).
In patients with overlap syndrome the VT/EMGdi decreased
from the state of wakefulness, to sleep in which snoring was
recorded (0.35±0.21 vs 0.24±0.14, p<0.001) and further
decreased during stage 2 hypopnoea events (0.15±0.12,
p<0.001) (table 3; data for stage 2 sleep with or without
snoring are shown in online supplementary table E-4).
DISCUSSION
In the present study we show that unlike healthy subjects who
exhibited a small (approximately 10%) difference between
NREM sleep and wakefulness, VE was lower in stage 2 sleep
than wakefulness in patients with COPD alone and those with
overlap syndrome or OSA. In patients with overlap syndrome
neural respiratory drive was similar between NREM sleep and
wakefulness. However, neural respiratory drive from wakeful-
ness to stage 2 sleep increased in patients with OSA but
decreased in those with COPD alone, suggesting that mild or
moderate OSA can partially compensate for reduction of neural
respiratory drive inherent to COPD and certainly does not seem
to worsen hypoventilation associated with COPD.
Methodological issues
This is the ﬁrst study to simultaneously record ventilation and
neural respiratory drive from patients with COPD alone and
patients with an overlap syndrome. Some studies have previ-
ously assessed ventilation during sleep using respiratory induct-
ance plethysmography,14–17 which can be inaccurate particularly
in patients with COPD.18 19 Becker et al18 used a pneumotacho-
graph to measure ventilation during sleep in patients with
COPD, but the pneumotachograph in their study was connected
with a nasal mask rather than a full-face mask, leading to a
potential underestimate of ventilation if patients breathed
through the mouth. Using a full face mask to quantify ventila-
tion we found a larger reduction of ventilation in NREM than
that reported by Becker et al18 using a nasal mask.
The FEV1 in patients with overlap syndrome was numerically,
although not statistically, higher than that in patients with
COPD alone. Because obesity is an important factor contribut-
ing to development of OSA and because COPD is a chronic
wasting disease sometimes associated with weight loss as disease
progresses, it could be argued that patients with severe COPD








Age (years) 62.0±9.2 61.5±10.2 58.1±8.3 55.8±8.9
BMI (kg/m2) 19.9±2.7 23.5±3.8 22.3±2.8 25.8±3.7
FVC%pred 73.7±19.9 68.5±17.4 98.6±9.6 100±12.6
FEV1%pred 38.5±16.3 47.5±16.2 98.1±9.2 99.1±14.6
FEV1/FVC% 41.3±11.2 54.6±11.4 79.6±3.4 80.4±6.3
mMRC 1.8±0.9 1.6±0.5 0±0 0±0
EMGdi-max (μV) 176.9±72.1 192.3±56.6 156.1±50.3 166.2±40.8
EMGdi-rest (μV) 29.5±13.3 29.3±15.8 12.6±3.7 14.2±7.9
AHI (events/
hour)
1.9±1.6 20.5±14.1 1.6±1.4 25.6±18
TST (hours) 4.4±2.0 3.9±1.8 4.2±1.4 5.6±1.8
Rest SaO2 (%) 96.8±1.4 97.1±1.3 98.0±1.0 96.9±0.7
Mean SaO2 (%) 96.0±1.6 95.8±1.4 97.6±0.9 96.1±1.4
Mini SaO2 (%) 90.6±5.3 90.9±3.9 93.6±2.4 85.3±8.7
TB90% 4.7±5.5 0.4±0.5 – 2.2±5.5
AHI, Apnoea Hypopnoea Index; BMI, body mass index; EMGdi-max, the maximum of
the diaphragm electromyogram; mean SaO2, mean nocturnal oxygen saturation; mini
SaO2, minimum nocturnal oxygen saturation; mMRC, modified British Medical
Research Council; TB90%, time spent with saturation below 90%; TST, total sleep
time.
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are less likely to develop OSA because of weight loss. However
the current dataset (by showing patients with COPD with poly-
somnographically proven OSA) shows that this conjecture is
insufﬁcient to prevent OSA in patients with COPD.20 21
However we note that while there was no statistically signiﬁcant
difference in FEV1 between patients with COPD alone and
those with overlap syndrome, type II error cannot be absolutely
excluded given the small numbers dictated by a physiological
study of this nature. We would also point out that the similarity
in mMRC score and EMGdi at rest between patients with
COPD alone and those with overlap syndrome also suggests the
severity of airway obstruction between the two groups is similar.
In the present study, the prevalence of overlap syndrome (46%)
seems to be high for a COPD cohort study, in particular for
those with low BMI. However, a high prevalence of overlap syn-
drome has recently been reported.9 21 Unlike Caucasian patients
with COPD,7–9 the BMI in Chinese patients with COPD is
usually low as previously reported.2 22 A high prevalence of
overlap syndrome (46%) in the COPD cohort study, despite the
low BMI, may thus be attributable to Asiatic craniofacial
morphology.23
Oesophageal pressure combined with airﬂow recordings has
recently been used to quantify upper airway resistance.24
However, oesophageal pressure is inﬂuenced by lung volume
and airﬂow and thus has a potential limitation in the assessment
of upper airway resistance in patients with OSA which is charac-
terised by changes in lung volume and airﬂow. Classically a cath-
eter positioned in the pharynx has been used to measure upper
airway resistance by measurement of pharyngeal pressure.25 26
However, upper airway resistance derived from measurement of
pharyngeal pressure is a difﬁcult technique and may be variable
during both wakefulness19 and sleep.26 Besides providing data
regarding neural respiratory drive, EMGdi has an advantage
over oesophageal pressure in the assessment of upper airway
resistance because it is independent of change in airﬂow and
lung volume.27 28 Normally, VT is achieved in response to
Table 2 Diaphragm EMG, ventilation during wakefulness and NREM sleep
COPD (n=19) Overlap (n=16)
Characteristics Wakefulness NREM △% p Value Wakefulness NREM △% p Value
EMGdi%max 29.5±13.3 23.0±8.9 22 0.006 29.3±15.8 27.3±14.7 7 0.38
VE (L) 8.6±2.0 6.5±1.5 24 <0.001 8.3±2.0 6.1±1.8 27 0.001
VT (L) 0.47±0.11 0.37±0.09 22 0.001 0.47±0.11 0.36±0.10 24 0.001
VT/EMGdi 0.39±0.23 0.37±0.21 5 0.92 0.35±0.21 0.28±0.19 20 0.041
ETCO2 (%) 4.5±0.5 4.5±0.6 0 0.89 4.7±0.7 4.7±0.8 0 0.48
RR 18.4±3.1 17.8±2.1 3 0.33 17.6±1.7 17.2±2.9 2 0.35
Normal (n=12) OSA (n=14)
EMGdi%max 12.6±3.7 12.2±3.3 3 0.84 14.2±7.9 23.4±10.8 65 0.001
VE (L) 8.3±1.6 7.5±1.3 10 0.07 8.0±2.7 6.3±1.9 21 0.006
VT (L) 0.50±0.09 0.49±0.10 2 0.56 0.48±0.16 0.39±0.10 19 0.008
VT/EMGdi 0.69±0.18 0.69±0.20 0 0.91 0.56±0.24 0.28±0.13 49 0.001
ETCO2 (%) 4.8±0.3 5.0±0.3 4 0.002 4.5±0.8 4.6±0.9 3 0.18
RR 16.7±2.3 15.6±2.3 7 0.10 16.6±3.0 16.0±2.3 4 0.27
△%, percentage change compared with wakefulness; EMGdi%max, percentage of maximal EMGdi; ETCO2, end-tidal CO2; NREM, non-rapid eye movement; p value, comparison of
wakefulness and NREM; RR, respiratory rate; VE, minute ventilation; VT, tidal volume; VT/EMGdi, the ratio of tidal volume to peak root mean square of EMGdi.
Figure 1 Diaphragm electromyogram (EMG) recording from ﬁve pairs of oesophageal electrodes and airﬂow from pneumotachography during
polysomnography in patients with COPD alone, patients with overlap syndrome, normal subjects and patients with obstructive sleep apnoea (OSA).
Diaphragm EMG decreases in patients with COPD alone but increases in patients with OSA from wakefulness to sleep, whereas it changes little in
patients with overlap syndrome and in normal subjects.
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neural respiratory drive reﬂected by EMGdi after overcoming
total respiratory resistance, including elastic recoil of the lung,
lower airway resistance and upper airway resistance. VT/EMGdi
reﬂects changes in upper airway resistance if lung mechanics
and lower airway resistance remain the same;2 one limitation of
our study which should therefore be acknowledged is that lung
volumes were not measured during sleep. OSA is characterised
by an increase in upper airway resistance from wakefulness to
snoring and a further increase to hypopnoea. In line with this
concept, VT/EMGdi decreases signiﬁcantly from wakefulness to
snoring and further decreases to hypopnoea in patients with
overlap syndrome, which supports using change in VT/EMGdi
to assess changes in upper airway resistance.
Signiﬁcance of ﬁndings
This study shows that neural drive decreases from the state of
wakefulness to sleep in patients with COPD alone, as previously
reported.2 3 19 It may be expected that neural respiratory drive
in patients with overlap syndrome would also decrease from
wakefulness to sleep, but we found that this is not the case, con-
sistent with our prior report that obstructive respiratory events
are associated with increased neural respiratory drive.10 Several
studies suggest that the increased neural respiratory drive during
sleep is directly related to the presence of increased upper
airway resistance since neural respiratory drive decreases when
airway resistance is offset by, for example, treatment with con-
tinuous positive airway pressure29 or inhalation of Heliox (76%
Figure 2 Electromyogram (EMG)di% (left panel), ventilation (middle panel) and the VT/EMGdi (right panel) in patients with COPD alone, overlap
syndrome, normal subjects and patients with obstructive sleep apnoea (OSA). Ventilation decreases from wakefulness to sleep in all four groups but
only in patients with COPD, overlap syndrome and OSA is the reduction statistically signiﬁcant. EMGdi decreases in patients with COPD alone but
increases in patients with OSA from wakefulness to non-rapid eye movement (NREM) sleep, whereas it remains the same in normal subjects and
patients with overlap syndrome. VT/EMGdi decreases from wakefulness to sleep in patients with overlap syndrome and those with OSA but it
changes little in normal subjects and patients with COPD alone. The decrease in ventilation is associated with a reduction of EMGdi in patients with
COPD alone whereas ventilation reduction is associated with decreased VT/EMGdi in patients with overlap syndrome and those with OSA.
Table 3 Diaphragm EMG (EMGdi), tidal volume (VT) and the efficacy of neural respiratory drive (VT/EMGdi) during wakefulness, snoring and
hypopnoea in patients with overlap syndrome
EMGdi/max% VT (mL/kg) VT/EMGdi
Overlap subjects Wakefulness Snoring Hypopnoea Wakefulness Snoring Hypopnoea Wakefulness Snoring Hypopnoea
1 49.0 54.7 48.1 5.1 4.0 1.2 0.10 0.07 0.02
2 23.1 25.2 25.4 5.8 4.1 2.6 0.25 0.16 0.10
3 28.1 37.8 35.3 10.2 7.5 3.2 0.36 0.20 0.09
4 58.3 50.8 52.8 5.6 4.3 1.9 0.10 0.08 0.04
5 21.0 18.2 14.8 9.3 6.9 5.1 0.44 0.38 0.34
6 31.3 22.3 12.1 5.9 8.3 2.4 0.19 0.37 0.20
7 17.1 23.4 22.8 9.5 7.5 4.1 0.56 0.32 0.18
8 48.9 38.7 39.1 7.0 3.6 2.3 0.14 0.09 0.06
9 18.2 23.3 18.1 8.5 6.4 4.5 0.47 0.27 0.25
10 12.3 18.1 12.9 9.3 9.3 4.9 0.76 0.51 0.38
11 14.9 22.0 18.7 8.5 4.3 1.8 0.57 0.19 0.10
12 17.1 19.5 20.2 8.9 4.3 1.7 0.52 0.22 0.08
13 25.4 29.2 24.2 6.3 4.4 2.1 0.25 0.15 0.09
14 14.0 13.0 12.6 7.3 6.1 4.4 0.52 0.47 0.35
15 58.7 55.3 46.2 5.8 3.7 2.8 0.10 0.07 0.06
16 30.9 24.2 28.8 6.1 4.9 2.2 0.20 0.20 0.08
Mean 29.3 29.7 27.0 7.4 5.6 2.9 0.35 0.24 0.15
SD 15.8 13.6 13.4 1.7 1.8 1.3 0.21 0.14 0.12
EMGdi%max, percentage of maximal diaphragm electromyogram.
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He/24%O2).
25 The present study suggests that sleep-related
reduction of neural respiratory drive characteristic of COPD
could be offset by an increase in upper airway resistance as a
consequence of coexistent OSA, in an adaptation potentially
protective in nature.
It has been hypothesised that desaturation in patients with
overlap syndrome would be more severe than that in patients
with COPD alone because COPD and OSA can cause desatur-
ation.6 7 30 However, this view is mainly derived from studies of
patients who had predominantly mild or moderate COPD or
who were recruited from patients with OSA and obesity,7 8 20 30
and thus may not represent a clinical cohort of patients with
severe COPD. However, a recent cohort study of non-obese
patients with severe COPD showed that the number of patients
with COPD alone who required oxygen supplementation was
similar to that in those with overlap syndrome,9 suggesting the
prevalence of oxygen desaturation is similar between patients
with COPD alone and patients with overlap syndrome. In the
present study we found that mean oxygen saturation and
minimal oxygen saturation during overnight sleep were similar
in patients with or without overlap syndrome. Moreover,
although patients with coexistent OSA and severe COPD
usually have brief periods of desaturation, prolonged desatur-
ation (SaO2<90 for longer than 5 min) occurred more often in
patients with severe COPD alone than those with overlap syn-
drome (see online supplementary table E-2). This ﬁnding may
be clinically signiﬁcant for the management of patients with
overlap syndrome. If sleep-related hypoventilation or desatur-
ation in patients with severe COPD had been worsened by coex-
istent OSA, one would have to be cautious with nutritional
supplements which may raise BMI in patients with COPD. In
contrast, the present study suggests that when patients with
severe COPD develop mild or moderate OSA, a sleep-related
reduction of neural respiratory drive as a consequence of COPD
would be relieved because of increased upper airway resistance,
preventing ventilation from further decreasing. The observation
that 16% of patients with COPD alone developed signiﬁcant
oxygen desaturation but none of patients with an overlap syn-
drome developed a signiﬁcant desaturation may give a hint that
if patients with severe COPD develop mild or moderate OSA,
oxygen desaturation would not necessarily be worsen. This
interesting ﬁnding is in line with the recent report that the clin-
ical outcome in end-stage patients with overlap syndrome is
better than those with COPD alone.31 Nevertheless, we note
that pathophysiological change in patients with overlap syn-
drome of severe COPD and mild OSA might differ from those
with mild COPD and severe OSA; in addition variation on this
spectrum may differ between western patients in whom OSA is
more driven by obesity and Asian patients (as studied here) in
whom craniofacial morphometry may be more relevant.
In conclusion the mechanism underlying the reduction of
ventilation at stage 2 sleep in patients with COPD alone differs
from that in patients with overlap syndrome. Ventilation reduc-
tion in patients with COPD alone is mainly because of a
decrease in neural respiratory drive whereas it is mainly a result
of an increase in upper airway resistance in patients with
overlap syndrome.
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